After repeated losses in the U.S., Catalyst wins a victory in Canada over a rare disease drug

3 June 2021 - In an unexpected move, Canada’s Federal Court quashed the approval of a rare disease drug after ...

Read more →

Suspend intellectual property rights for COVID-19 vaccines

28 May 2021 - Waivers are essential for global vaccine equity ...

Read more →

Vaccine patent waivers deserve a warning label

13 May 2021 - The move to suspend patents on COVID-19 vaccines opens up a major risk to the way the ...

Read more →

International IP protection at risk for COVID-19 vaccines

11 May 2021 - The global biotech industry is united in its drive for equitable access to COVID-19 vaccines, but ...

Read more →

America wants to waive patent protection for vaccines

8 May 2021 - But it will not have an immediate effect on supplies. ...

Read more →

US wary of boosting China biotech with COVID vaccine patent waiver

9 May 2021 - The Biden administration is examining ways to ensure that a waiver of COVID-19 vaccine patents to ...

Read more →

Medicines Australia updated position on intellectual property (in light of TRIPS waiver)

6 May 2021 - Medicines Australia continues to express our sympathies to all those affected by the pandemic. The importance ...

Read more →

Australia has backed a global push to fast-track generic COVID-19 jabs

6 May 2021 - The Morrison government has joined an international push to fast-track the production of generic COVID-19 jabs, ...

Read more →

European Patent Office rules in favour of Sanofi and Regeneron concerning Praluent (alirocumab)

29 October 2020 - Ruling invalidates Amgen’s European patent claims directed to PCSK9 antibodies relevant to Praluent (alirocumab). ...

Read more →

Moderna vows to not enforce COVID-19 vaccine patents during pandemic

8 October 2020 - The company is also willing to license the technology behind its experimental coronavirus vaccine. ...

Read more →

AstraZeneca vaccine document shows limit of no-profit pledge

8 October 2020 - Company has right under contract to declare pandemic over by July 2021. ...

Read more →

Direct or indirect comparison: reliance on innovative drug data key to engaging data protection

15 August 2020 - The Federal Court recently issued its decision in Natco v Canada (Minister of Health), 2020 FC 788, ...

Read more →

Moderna’s mysterious coronavirus vaccine delivery system

29 July 2020 - For a decade, Moderna has been working to develop mRNA technology that could turn the body’s cells ...

Read more →

Coronavirus puts big pharma’s IP regime to the test

21 April 2020 - “Chaotic” is how Jorge Contreras, a law professor at the University of Utah, describes a struggle ...

Read more →

Expanding access and reducing prices for drugs to prevent HIV. Should Government enforce its patent rights against the pharmaceutical industry?

3 March 2020 - On November 6, 2019, the Department of Health and Human Services (HHS) filed a lawsuit against Gilead ...

Read more →